Ginkgo biloba

( DrugBank: Ginkgo biloba / KEGG DRUG: Ginkgo )


4 diseases
IDDisease name (Link within this page)Number of trials
13Multiple sclerosis/Neuromyelitis optica2
18Spinocerebellar degeneration1
IDDisease name (Link within this page)Number of trials
47Buerger disease1
90Retinitis pigmentosa1

13. Multiple sclerosis/Neuromyelitis optica


Clinical trials : 3,898 / Drugs : 2,785 - (DrugBank : 360) / Drug target genes : 265 - Drug target pathways : 239 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

18. Spinocerebellar degeneration


Clinical trials : 144 / Drugs : 174 - (DrugBank : 40) / Drug target genes : 50 - Drug target pathways : 75 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

47. Buerger disease


Clinical trials : 21 / Drugs : 26 - (DrugBank : 14) / Drug target genes : 7 - Drug target pathways : 19 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

90. Retinitis pigmentosa


Clinical trials : 203 / Drugs : 267 - (DrugBank : 49) / Drug target genes : 55 - Drug target pathways : 162 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries